Search filters

List of works by Marion E Meijer-van Gelder

A Method to Correlate mRNA Expression Datasets Obtained from Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Tissue Samples: A Matter of Thresholds.

scientific article published on 30 December 2015

Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer

scientific article published in May 2005

Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response

scientific article

Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration

scientific article published on 26 September 2016

CHEK2 1100delC and male breast cancer in the Netherlands

scientific article published on 31 August 2008

Cell-free DNA mutations as biomarkers in breast cancer patients receiving tamoxifen

scientific article

Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer.

scientific article published in April 2003

Concentrations of TIMP1 mRNA splice variants and TIMP-1 protein are differentially associated with prognosis in primary breast cancer

scientific article published on 03 May 2007

DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients

scientific article published on 28 October 2007

Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer

scientific article published on 16 July 2008

Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancers

scientific article

Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424).

scientific article published in August 2002

Evaluation of the ability of adjuvant tamoxifen-benefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive breast cancer patients treated with tamoxifen in the advanced setting.

scientific article published on 10 July 2014

GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease.

scientific article

HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study

scientific article

How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study

scientific article published in October 2005

Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer

scientific article

MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer

scientific article published on 19 May 2010

Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling

scientific article published in February 2005

Molecular profiling of platinum resistant ovarian cancer.

scientific article published in April 2006

Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patients

scientific article published on 01 September 2003

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients

scientific article published on 01 January 2002

Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer

scientific article published on 17 November 2006

Production of P-glycoprotein from the MDR1 upstream promoter is insufficient to affect the response to first-line chemotherapy in advanced breast cancer

scientific article published on 01 March 2008

RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.

scientific article

Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance

scientific article

Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response

scientific article

Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriers

scientific article

The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer

scientific article

The CYP2C19*2 genotype predicts tamoxifen treatment outcome in advanced breast cancer patients

scientific article published on 10 August 2011

The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer.

scientific article published on 07 October 2016

The Prevalence of CD146 Expression in Breast Cancer Subtypes and Its Relation to Outcome.

scientific article published on 5 May 2018

The prognostic value of BCAR1 in patients with primary breast cancer.

scientific article published on September 2004

Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study

scientific article published on 10 September 2009

Tumor tissue levels of tissue inhibitor of metalloproteinase-1 as a prognostic marker in primary breast cancer

scientific article published in April 2004

Urokinase receptor splice variant uPAR-del4/5-associated gene expression in breast cancer: identification of rab31 as an independent prognostic factor

scientific article published on 20 October 2007

Urokinase-type plasminogen activator system in breast cancer: association with tamoxifen therapy in recurrent disease

scientific article

Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients

scientific article published on 01 June 2006

Paulina is supported by:

About Paulina

Help